Baidu
map

肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

胶质瘤多学科诊治（MDT）中国专家共识

2018-02-20 中国医师协会神经外科医师分会 中华神经外科杂志.2018.34(2):113-118.

胶质瘤多学科诊治

在国外，多学科综合治疗协作组(MDT)已成为肿瘤治疗的标准。 2008年在中华医学会神经外科学分会的领导下，发表了多学科专家编写的《中国中枢神经系统恶性胶质瘤诊断和治疗共识》，随在2011年进行了更新和扩容编写成指南，并于2015年再次更新，新指南推荐MDT模式治疗脑胶质瘤。 基于MDT在肿瘤治疗中的价值，为了进一步推动MDT在我国胶质瘤诊疗中的运用，并规范胶质瘤MDT模式，中国医师协会神

中文标题：

胶质瘤多学科诊治（MDT）中国专家共识

发布机构：

中国医师协会神经外科医师分会

发布日期：

2018-02-20

简要介绍：

在国外，多学科综合治疗协作组(MDT)已成为肿瘤治疗的标准。 2008年在中华医学会神经外科学分会的领导下，发表了多学科专家编写的《中国中枢神经系统恶性胶质瘤诊断和治疗共识》，随在2011年进行了更新和扩容编写成指南，并于2015年再次更新，新指南推荐MDT模式治疗脑胶质瘤。

基于MDT在肿瘤治疗中的价值，为了进一步推动MDT在我国胶质瘤诊疗中的运用，并规范胶质瘤MDT模式，中国医师协会神经外科医师分会脑胶质瘤专业委员会组织国内胶质瘤领域的多学科专家撰写了本共识。

 

拓展指南：与胶质瘤相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=胶质瘤多学科诊治（MDT）中国专家共识)] GetToolGuiderByIdResponse(projectId=1, id=0f95c1c0015e39cf, title=胶质瘤多学科诊治（MDT）中国专家共识, enTitle=, guiderFrom=中华神经外科杂志.2018.34(2):113-118., authorId=null, author=, summary=在国外，多学科综合治疗协作组(MDT)已成为肿瘤治疗的标准。 2008年在中华医学会神经外科学分会的领导下，发表了多学科专家编写的《中国中枢神经系统恶性胶质瘤诊断和治疗共识》，随在2011年进行了更新和扩容编写成指南，并于2015年再次更新，新指南推荐MDT模式治疗脑胶质瘤。 基于MDT在肿瘤治疗中的价值，为了进一步推动MDT在我国胶质瘤诊疗中的运用，并规范胶质瘤MDT模式，中国医师协会神, cover=, journalId=null, articlesId=null, associationId=289, associationName=中国医师协会神经外科医师分会, associationIntro=null, copyright=0, guiderPublishedTime=Tue Feb 20 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>在国外，多学科综合治疗协作组(MDT)已成为肿瘤治疗的标准。 2008年在中华医学会神经外科学分会的领导下，发表了多学科专家编写的《中国中枢神经系统恶性胶质瘤诊断和治疗共识》，随在2011年进行了更新和扩容编写成指南，并于2015年再次更新，新指南推荐MDT模式治疗脑胶质瘤。 <BR><BR>基于MDT在肿瘤治疗中的价值，为了进一步推动MDT在我国胶质瘤诊疗中的运用，并规范胶质瘤MDT模式，中国医师协会神经外科医师分会脑胶质瘤专业委员会组织国内胶质瘤领域的多学科专家撰写了本共识。</P> <P> </P>拓展指南：<strong>与<font color=red>胶质瘤</font>相关指南：</strong><br><ul><li><a href="//m.sandwebs.com/guideline/show_article.do?id=426d11c001553ecf" title="胶质瘤放疗中国专家共识（2017）" target=_blank>胶质瘤放疗中国专家共识（2017）</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=558d41c0015a955a" title="中国中枢神经系统胶质瘤免疫和靶向治疗专家共识" target=_blank>中国中枢神经系统胶质瘤免疫和靶向治疗专家共识</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=ebd111c001ae24fc" title="脑干胶质瘤综合诊疗中国专家共识" target=_blank>脑干胶质瘤综合诊疗中国专家共识</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=653691c001a54654" title="2017 EANO指南：成人神经胶质瘤的姑息治疗" target=_blank>2017 EANO指南：成人神经胶质瘤的姑息治疗</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=6435b1c00125591a" title="2016 成人幕上低级别胶质瘤的手术治疗指南" target=_blank>2016 成人幕上低级别胶质瘤的手术治疗指南</a></li> 更多信息请点击：<a href="//m.sandwebs.com/guideline/list.do?q=%E8%83%B6%E8%B4%A8%E7%98%A4" target=_blank>有关胶质瘤更多指南</a></ul>, tagList=[TagDto(tagId=691, tagName=胶质瘤), TagDto(tagId=72463, tagName=多学科诊治)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=25, categoryName=神经外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8383, appHits=356, showAppHits=5, pcHits=5472, showPcHits=3484, likes=141, shares=12, comments=6, approvalStatus=1, publishedTime=Sat Mar 31 11:17:06 CST 2018, publishedTimeString=2018-02-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Mar 31 11:17:06 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 05:49:53 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=胶质瘤多学科诊治（MDT）中国专家共识)])
胶质瘤多学科诊治（MDT）中国专家共识
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=302342, encodeId=59e730234266, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue Apr 03 09:15:13 CST 2018, time=2018-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301538, encodeId=0531301538e9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Sat Mar 31 16:41:10 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301531, encodeId=1bd0301531c8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sat Mar 31 16:39:41 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301522, encodeId=1dc1301522c7, content=学习了.谢谢分享., beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sat Mar 31 16:23:08 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301507, encodeId=2ec730150e2b, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sat Mar 31 15:52:14 CST 2018, time=2018-03-31, status=1, ipAttribution=)]
    2018-04-03 大爰

    学习了谢谢分享!!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=302342, encodeId=59e730234266, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue Apr 03 09:15:13 CST 2018, time=2018-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301538, encodeId=0531301538e9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Sat Mar 31 16:41:10 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301531, encodeId=1bd0301531c8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sat Mar 31 16:39:41 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301522, encodeId=1dc1301522c7, content=学习了.谢谢分享., beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sat Mar 31 16:23:08 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301507, encodeId=2ec730150e2b, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sat Mar 31 15:52:14 CST 2018, time=2018-03-31, status=1, ipAttribution=)]
    2018-03-31 121832a9m88暂无昵称

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=302342, encodeId=59e730234266, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue Apr 03 09:15:13 CST 2018, time=2018-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301538, encodeId=0531301538e9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Sat Mar 31 16:41:10 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301531, encodeId=1bd0301531c8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sat Mar 31 16:39:41 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301522, encodeId=1dc1301522c7, content=学习了.谢谢分享., beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sat Mar 31 16:23:08 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301507, encodeId=2ec730150e2b, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sat Mar 31 15:52:14 CST 2018, time=2018-03-31, status=1, ipAttribution=)]
    2018-03-31 秀红

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=302342, encodeId=59e730234266, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue Apr 03 09:15:13 CST 2018, time=2018-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301538, encodeId=0531301538e9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Sat Mar 31 16:41:10 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301531, encodeId=1bd0301531c8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sat Mar 31 16:39:41 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301522, encodeId=1dc1301522c7, content=学习了.谢谢分享., beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sat Mar 31 16:23:08 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301507, encodeId=2ec730150e2b, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sat Mar 31 15:52:14 CST 2018, time=2018-03-31, status=1, ipAttribution=)]
    2018-03-31 惠映实验室

    学习了.谢谢分享.

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=302342, encodeId=59e730234266, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue Apr 03 09:15:13 CST 2018, time=2018-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301538, encodeId=0531301538e9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Sat Mar 31 16:41:10 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301531, encodeId=1bd0301531c8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sat Mar 31 16:39:41 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301522, encodeId=1dc1301522c7, content=学习了.谢谢分享., beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sat Mar 31 16:23:08 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301507, encodeId=2ec730150e2b, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sat Mar 31 15:52:14 CST 2018, time=2018-03-31, status=1, ipAttribution=)]
    2018-03-31 神功盖世

    阅

    0

相关指南

胶质瘤放疗中国专家共识（2017）

中华医学会放射肿瘤学会 · 2018-02-07

脑干胶质瘤综合诊疗中国专家共识

中华医学会神经外科学分会 · 2017-04-04

2017 EANO指南：成人神经胶质瘤的姑息治疗

欧洲神经肿瘤协会(EANO,European Association for Neuro-Oncology) · 2017-06-10

2016 成人幕上低级别胶质瘤的手术治疗指南

中国脑胶质瘤协作组 · 2016-07-30

唤醒状态下切除脑功能区胶质瘤手术技术指南（2014版）

中国脑胶质瘤协作组 · 2014-10-20

2014 EANO指南：未分化神经胶质瘤和胶质母细胞瘤的诊断和治疗

欧洲神经肿瘤协会(EANO,European Association for Neuro-Oncology) · 2014-08-15

Baidu
map
Baidu
map
Baidu
map